LLY

1,010.53

-2.15%↓

JNJ

202.19

-1.57%↓

ABBV

228.68

-0.7%↓

UNH

333.72

-1.99%↓

AZN

89.97

-0.96%↓

LLY

1,010.53

-2.15%↓

JNJ

202.19

-1.57%↓

ABBV

228.68

-0.7%↓

UNH

333.72

-1.99%↓

AZN

89.97

-0.96%↓

LLY

1,010.53

-2.15%↓

JNJ

202.19

-1.57%↓

ABBV

228.68

-0.7%↓

UNH

333.72

-1.99%↓

AZN

89.97

-0.96%↓

LLY

1,010.53

-2.15%↓

JNJ

202.19

-1.57%↓

ABBV

228.68

-0.7%↓

UNH

333.72

-1.99%↓

AZN

89.97

-0.96%↓

LLY

1,010.53

-2.15%↓

JNJ

202.19

-1.57%↓

ABBV

228.68

-0.7%↓

UNH

333.72

-1.99%↓

AZN

89.97

-0.96%↓

Search

Maravai LifeSciences Holdings Inc (Class A)

Fechado

3.72 5.98

Visão Geral

Variação de preço das ações

24h

Atual

Mín

3.45

Máximo

3.75

Indicadores-chave

By Trading Economics

Rendimento

44M

-26M

Vendas

-5.8M

42M

Margem de lucro

-61.388

Funcionários

550

EBITDA

44M

-22M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+16.28% upside

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

162M

1.2B

Abertura anterior

-2.26

Fecho anterior

3.72

Pontuação Técnica

By Trading Central

Confiança

Bullish Evidence

Maravai LifeSciences Holdings Inc (Class A) Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

4 de dez. de 2025, 20:41 UTC

Ganhos
Grandes Movimentos do Mercado

America's Car-Mart Rises on Better-Than-Expected 2Q Revenue, $300 Million Term Loan

4 de dez. de 2025, 18:14 UTC

Aquisições, Fusões, Aquisições de Empresas

Big Yellow Says It Will Terminate Takeover Talks With Blackstone

4 de dez. de 2025, 17:43 UTC

Grandes Movimentos do Mercado
Aquisições, Fusões, Aquisições de Empresas

Brera Holdings Signs Non-Binding Term Sheet to Acquire RockawayX

4 de dez. de 2025, 17:01 UTC

Ganhos

TD Bank Pushes Up Dividend After Underlying Earnings, Revenue Beat Expectations -- Update

4 de dez. de 2025, 23:45 UTC

Conversa de Mercado

Nikkei May Decline Amid Caution Over U.S. Labor Market, Japan Earnings -- Market Talk

4 de dez. de 2025, 23:45 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

4 de dez. de 2025, 21:54 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

4 de dez. de 2025, 21:54 UTC

Conversa de Mercado

Warehouse's Strategy to Lift Margins Easier Said Then Done -- Market Talk

4 de dez. de 2025, 21:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

4 de dez. de 2025, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

4 de dez. de 2025, 21:48 UTC

Conversa de Mercado

Scales Hits Mark With Earnings Guidance -- Market Talk

4 de dez. de 2025, 21:37 UTC

Ganhos

Aerospace Start-Up Beta Posts Its First Earnings Report. The Stock Rises. -- Barrons.com

4 de dez. de 2025, 21:36 UTC

Ganhos

These Stocks Moved the Most Today: Meta Platforms, Salesforce, Snowflake, UiPath, Micron, Dollar General, Kroger, and More -- Barrons.com

4 de dez. de 2025, 20:15 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

4 de dez. de 2025, 20:15 UTC

Conversa de Mercado

Think Tank Calls For Bank of Canada Rate Hold Next Week -- Market Talk

4 de dez. de 2025, 20:04 UTC

Conversa de Mercado

Natural Gas Futures Extend Gains as U.S. Grows Cold -- Market Talk

4 de dez. de 2025, 19:54 UTC

Conversa de Mercado

Oil Futures Bolstered by Lasting Ukraine War, U.S. Macro Outlook -- Market Talk

4 de dez. de 2025, 19:44 UTC

Aquisições, Fusões, Aquisições de Empresas

EQB CEO: PC Financial Deal Adds Scale to Compete With Larger Canadian Banks

4 de dez. de 2025, 19:44 UTC

Aquisições, Fusões, Aquisições de Empresas

EQB CEO: PC Financial Tie-Up Brings Scale to Reach More Customers

4 de dez. de 2025, 19:44 UTC

Aquisições, Fusões, Aquisições de Empresas

Equitable Bank Deal for PC Financial Adds Heft to Compete With Canada's Big Banks -- Interview

4 de dez. de 2025, 19:33 UTC

Conversa de Mercado

Gold Inches Higher as Traders Continue to Mull ADP Jobs Report -- Market Talk

4 de dez. de 2025, 19:01 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount Raises Concerns About Netflix's Bid for Warner Bros. Discovery -- WSJ

4 de dez. de 2025, 19:01 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount Wrote to Warner Bros. Discovery Again Wednesday -- WSJ

4 de dez. de 2025, 19:01 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount Wrote Netflix Deal With Warner Bros. Would Likely 'Never Close,' Monday Letter Says -- WSJ

4 de dez. de 2025, 19:01 UTC

Aquisições, Fusões, Aquisições de Empresas

Another Round of Bids for Warner Bros. Discovery Due Thursday, Sources Say -- WSJ

4 de dez. de 2025, 18:58 UTC

Conversa de Mercado

U.S.-Venezuela Military Tension Expected to Lift Oil Prices -- Market Talk

4 de dez. de 2025, 17:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

4 de dez. de 2025, 17:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

4 de dez. de 2025, 16:41 UTC

Conversa de Mercado

Gold Rises as Traders Await U.S. Inflation Data -- Market Talk

4 de dez. de 2025, 16:33 UTC

Conversa de Mercado
Ganhos

Salesforce Customers Are Gaining Confidence in Agentforce -- Market Talk

Comparação entre Pares

Variação de preço

Maravai LifeSciences Holdings Inc (Class A) Previsão

Preço-alvo

By TipRanks

16.28% parte superior

Previsão para 12 meses

Média 4 USD  16.28%

Máximo 4 USD

Mínimo 4 USD

Com base em 3 analistas de Wall Street que oferecem metas de preço de 12 meses para Maravai LifeSciences Holdings Inc (Class A) - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

3 ratings

2

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

2.02 / 2.115Suporte e Resistência

Curto Prazo

Bullish Evidence

Médio Prazo

Strong Bullish Evidence

Longo Prazo

No Evidence

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Maravai LifeSciences Holdings Inc (Class A)

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as custom enzyme development and manufacturing and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody, and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. The company was incorporated in 2020 and is headquartered in San Diego, California.
help-icon Live chat